What is the share price of India Glycols Ltd (INDIAGLYCO) today?
The share price of INDIAGLYCO as on 15th September 2026 is ₹280.20. The stock prices are volatile and keep changing through the day depending upon various factors and market conditions.What is the return on India Glycols Ltd (INDIAGLYCO) share?
The past returns of India Glycols Ltd (INDIAGLYCO) share are- Past 1 week: 13.25%
- Past 1 month: 33.68%
- Past 3 months: 54.24%
- Past 6 months: 67.90%
- Past 1 year: 74.81%
- Past 3 years: 287.38%
- Past 5 years: 317.40%
What are the peers or stocks similar to India Glycols Ltd (INDIAGLYCO)?
The peers or stocks similar to India Glycols Ltd (INDIAGLYCO) include:What is the dividend yield % of India Glycols Ltd (INDIAGLYCO) share?
The current dividend yield of India Glycols Ltd (INDIAGLYCO) is 2.54.What is the market cap of India Glycols Ltd (INDIAGLYCO) share?
Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of India Glycols Ltd (INDIAGLYCO) is ₹1976.62 Cr as of 15th September 2026.What is the 52 week high and low of India Glycols Ltd (INDIAGLYCO) share?
The 52-week high of India Glycols Ltd (INDIAGLYCO) is ₹316.30 and the 52-week low is ₹160.40.What is the PE and PB ratio of India Glycols Ltd (INDIAGLYCO) stock?
The P/E (price-to-earnings) ratio of India Glycols Ltd (INDIAGLYCO) is 6.75. The P/B (price-to-book) ratio is 0.67.Which sector does India Glycols Ltd (INDIAGLYCO) belong to?
India Glycols Ltd (INDIAGLYCO) belongs to the Materials sector & Commodity Chemicals sub-sector.How to buy India Glycols Ltd (INDIAGLYCO) shares?
You can directly buy India Glycols Ltd (INDIAGLYCO) shares on Tickertape. Simply sign up, connect your demat account and place your order.
India Glycols Ltd
INDIAGLYCO Share Price
NSE₹280.204.98% (-14.70)
High
—
—
Low
—
—
Returns
—
—
1D
1W
1M
1Y
5Y
Max
SIP
1D
1W
1M
1Y
5Y
Max
SIP
INDIAGLYCO Stock Scorecard
Performance
AvgPrice return has been average, nothing exciting
Valuation
HighSeems to be overvalued vs the market average
Growth
AvgFinancials growth has been moderate for a few years
Profitability
HighShowing good signs of profitability & efficiency
Entry point
GoodThe stock is underpriced and is not in the overbought zone
Red flags
LowNo red flag found
How to use scorecard? Learn more
INDIAGLYCO Performance & Key Metrics
INDIAGLYCO Performance & Key Metrics
| No LabelNo Label | PB RatioPB Ratio | Dividend YieldDiv. Yield |
|---|---|---|
| 6.25 | 0.67 | 2.54% |
| Sector PESector PE | Sector PBSector PB | Sector Div YldSctr Div Yld |
|---|---|---|
| 24.34 | 3.05 | 1.42% |
INDIAGLYCO Analyst Ratings & Forecast
—
Analyst Ratings data is currently unavailable for this stockPrice Upside
Earnings Growth
Rev. Growth
INDIAGLYCO Company Profile
India Glycols Limited is a company engaged in the manufacturing of technology-based bulk, specialty and performance chemicals, natural gums, spirits, industrial gases, sugar and nutraceuticals.
SOLARINDS
PE Ratio
120.24
120.24
1Y Return
59.39%
59.39%
Buy Reco %
78.57
78.57
LINDEINDIA
PE Ratio
96.75
96.75
1Y Return
3.34%
3.34%
Buy Reco %
0.00
0.00
PE Ratio
44.65
44.65
1Y Return
39.99%
39.99%
Buy Reco %
0.00
0.00
SUMICHEM
PE Ratio
43.79
43.79
1Y Return
16.40%
16.40%
Buy Reco %
88.89
88.89
DEEPAKNTR
PE Ratio
39.34
39.34
1Y Return
9.24%
9.24%
Buy Reco %
58.82
58.82
INDIAGLYCO Sentiment Analysis
INDIAGLYCO Sentiment Analysis
New
Crisp summary & key insights to decode earnings calls instantly
INDIAGLYCO Stock Summary · August 2026
Management said the quarter marked a strong start to FY27, with higher profitability across the restructured businesses and a clear mix shift toward better-quality earnings. Consolidated revenue rose 9% year on year to INR 1,130 crores, while EBITDA increased 13% to INR 170 crores, lifting margin to 15.0% from 14.3%; this was supported by premiumisation, improved business quality and lower finance costs after debt reduction. Spirits was the main growth engine, with IMFL revenue up 26% and volumes up 55% to 1.4 million cases, while the company also highlighted broad-based improvement in chemicals and a breakout quarter in bio pharma. At the same time, management acknowledged pressure in parts of chemicals from a record-low rupee, higher freight, raw material inflation and supply-chain disruption, even as some India-linked pricing improved off-take. Looking ahead, the company said the approved demerger will sharpen business focus, and it reiterated FY27 spirits EBITDA of more than INR 500 crores, IMFL at over 30% of potable spirits revenue, and spirits volumes roughly doubling, with healthy double-digit growth expected next year.
INDIAGLYCO Stock Growth Drivers
INDIAGLYCO Stock Growth Drivers
12Investor engagement and leadership strengthening
Management added a new investor relations lead and a new chief operating officer for the
Strong Q1 FY27 financial and operating performance
The company delivered a very strong start to FY27, with net revenue of INR1,130 crores,
INDIAGLYCO Stock Challenges
INDIAGLYCO Stock Challenges
4Supply Chain, Freight, and Input Cost Disruption
The business faced significant operating pressure from an adverse external environment characterized by war-related disruptions,
Weak Export Performance in Chemicals
Export-facing parts of the chemicals business underperformed because of demand weakness and logistical constraints in
INDIAGLYCO Forecast
INDIAGLYCO Forecasts
Forecast data is currently unavailable
Forecast data is currently unavailable
Price
Price Upside
Revenue
Revenue Growth
Earnings
Earnings Per Share
INDIAGLYCO
INDIAGLYCO
Income
Balance Sheet
Cash Flow
Quarterly Normal View
INDIAGLYCO Income Statement
INDIAGLYCO Income Statement
Quarterly Normal View
| Quarter | mar 2024 | jun 2024 | sep 2024 | dec 2024 | mar 2025 | jun 2025 | sep 2025 | dec 2025 | mar 2026 | jun 2026 | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 935.83 | 982.16 | 976.36 | 994.50 | 876.19 | 1,060.48 | 1,105.93 | 1,106.40 | 989.95 | 1,151.37 | ||||||||||
Operating & Other expenses | 821.56 | 843.08 | 845.42 | 851.54 | 717.28 | 890.82 | 934.56 | 927.76 | 809.85 | 960.83 | ||||||||||
EBITDA | 114.27 | 139.08 | 130.94 | 142.96 | 158.91 | 169.66 | 171.37 | 178.64 | 180.10 | 190.54 | ||||||||||
| Depreciation/Amortization | 26.04 | 27.57 | 27.57 | 27.47 | 32.59 | 34.45 | 38.48 | 41.22 | 41.23 | 42.48 | ||||||||||
| PBIT | 88.23 | 111.51 | 103.37 | 115.49 | 126.32 | 135.21 | 132.89 | 137.42 | 138.87 | 148.06 | ||||||||||
| Interest & Other Items | 32.63 | 35.86 | 39.91 | 44.07 | 44.53 | 44.68 | 49.28 | 46.81 | 26.41 | 25.18 | ||||||||||
| PBT | 55.60 | 75.65 | 63.46 | 71.42 | 81.79 | 90.53 | 83.61 | 90.61 | 112.46 | 122.88 | ||||||||||
| Taxes & Other Items | 13.39 | 15.27 | 13.75 | 14.61 | 17.77 | 17.28 | 18.55 | 23.04 | 25.58 | 26.05 | ||||||||||
| Net Income | 42.21 | 60.38 | 49.71 | 56.81 | 64.02 | 73.25 | 65.06 | 67.57 | 86.88 | 96.83 | ||||||||||
| EPS | 1.38 | 1.97 | 1.62 | 1.86 | 2.09 | 2.39 | 2.13 | 2.18 | 2.76 | 2.92 |
INDIAGLYCO Company Updates
FY 2027FY 2027
Investor Presentation
Sep 2PDF
Sep 2PDF
Sep 2PDF
+2 more
INDIAGLYCO Stock Peers
INDIAGLYCO Past Performance & Peer Comparison
INDIAGLYCO Past Performance & Peer Comparison
Comparing 3 stocks from
MaterialsCommodity Chemicals
Compare valuation on Screener
MaterialsCommodity Chemicals
Valuation
Technical
Forecast
Compare valuation on Screener| Stock | PE RatioPE Ratio | PB RatioPB Ratio | Div. YieldDividend Yield |
|---|---|---|---|
| India Glycols Ltd | 6.75 | 0.67 | 2.54% |
| Solar Industries India Ltd | 120.24 | 30.80 | 0.05% |
| Linde India Ltd | 96.75 | 12.45 | 0.19% |
| Himadri Speciality Chemical Ltd | 44.65 | 7.05 | 0.12% |
INDIAGLYCO Stock Price Comparison
Compare INDIAGLYCO with any stock or ETFCompare INDIAGLYCO with any stock or ETF
INDIAGLYCO
INDIAGLYCO Holdings
INDIAGLYCO Shareholdings
INDIAGLYCO Promoter Holdings Trend
INDIAGLYCO Promoter Holdings Trend
Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook
In last 6 months, promoter holding in the company has almost stayed constant
Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better
Pledged promoter holdings is insignificant
INDIAGLYCO Institutional Holdings Trend
INDIAGLYCO Institutional Holdings Trend
Total Retail Holding
Increasing retail holding can be considered bad as it can reflect that institutions and promoters are selling their stake which is being absorbed by retail investors.
In last 3 months, retail holding in the company has almost stayed constant
Foreign Institutional Holding
Foreign Institutional Holding is quantum of stock held by foreign large-quantities-trading entities. Increasing value indicates growing support and comfort for the stock
In last 3 months, foreign institutional holding of the company has almost stayed constant
INDIAGLYCO Shareholding Pattern
INDIAGLYCO Shareholding Pattern
INDIAGLYCO Shareholding History
INDIAGLYCO Shareholding History
Foreign Institutions
Mutual Funds Invested in INDIAGLYCO
Mutual Funds Invested in INDIAGLYCO
No mutual funds holding trends are available
Top 5 Mutual Funds holding India Glycols Ltd
| Funds (Top 5) | The rupee value of the stock held by the fund divided by the stock’s market cap Market-cap held | Percentage of the fund’s portfolio invested in the stock Weight | Change in the portfolio weight of the stock over the last 3 months 3M holding change | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months Portfolio rank(3M change) |
|---|---|---|---|---|
The rupee value of the stock held by the fund divided by the stock’s market cap 0.1153% | Percentage of the fund’s portfolio invested in the stock 0.49% | Change in the portfolio weight of the stock over the last 3 months 0.02% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 38/112 (-5) | |
The rupee value of the stock held by the fund divided by the stock’s market cap 0.0871% | Percentage of the fund’s portfolio invested in the stock 0.27% | Change in the portfolio weight of the stock over the last 3 months 0.02% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 103/256 (+24) | |
The rupee value of the stock held by the fund divided by the stock’s market cap 0.0006% | Percentage of the fund’s portfolio invested in the stock 0.01% | Change in the portfolio weight of the stock over the last 3 months 0.00% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 229/755 (+205) |
Compare 3-month MF holding change on Screener
Hmm, looks like there hasn't been any net deal activity in the last 6 monthssmallcases containing INDIAGLYCO stock
smallcases containing INDIAGLYCO stock
Looks like this stock is not in any smallcase yet.
INDIAGLYCO Events
INDIAGLYCO Events
INDIAGLYCO Dividend Trend
No Dividend Cuts
Dividends are the portion of earnings that a company distributes to all its shareholders every year
INDIAGLYCO has increased or maintained dividend levels over the last 5 years
Dividend Yield
Dividend return is one of the most important things to be considered while investing for long term. It is the additional return on top of what investors earn through price appreciation
Current dividend yield is 0.65%. An investment of ₹1,000 in the stock is expected to generate dividend of ₹6.54 every year
Dividends
Corp. Actions
Announcements
Legal Orders
Dividends
INDIAGLYCO Dividend Trend
No Dividend Cuts
Dividends are the portion of earnings that a company distributes to all its shareholders every year
INDIAGLYCO has increased or maintained dividend levels over the last 5 years
Dividend Yield
Dividend return is one of the most important things to be considered while investing for long term. It is the additional return on top of what investors earn through price appreciation
Current dividend yield is 0.65%. An investment of ₹1,000 in the stock is expected to generate dividend of ₹6.54 every year
INDIAGLYCO Upcoming Dividends
INDIAGLYCO Upcoming Dividends
No upcoming dividends are available
INDIAGLYCO Past Dividends
INDIAGLYCO Past Dividends
Cash Dividend
Ex DateEx DateMar 23, 2026
Interim
Interim | Div/Share: ₹7.50
Dividend/Share
₹7.50
Ex DateEx Date
Mar 23, 2026
Cash Dividend
Ex DateEx DateSep 23, 2025
Final
Final | Div/Share: ₹5.00
Dividend/Share
₹5.00
Ex DateEx Date
Sep 23, 2025
Cash Dividend
Ex DateEx DateAug 21, 2024
Final
Final | Div/Share: ₹8.00
Dividend/Share
₹8.00
Ex DateEx Date
Aug 21, 2024
Cash Dividend
Ex DateEx DateSep 5, 2023
Final
Final | Div/Share: ₹7.50
Dividend/Share
₹7.50
Ex DateEx Date
Sep 5, 2023
Cash Dividend
Ex DateEx DateAug 29, 2022
Final
Final | Div/Share: ₹7.50
Dividend/Share
₹7.50
Ex DateEx Date
Aug 29, 2022
INDIAGLYCO Stock News & Opinions
INDIAGLYCO Stock News & Opinions
Articles & Videos
Corporate
Corporate
India Glycols confirms departure of four senior managers due to employment transfersIndia Glycols Limited informed the BSE Limited and National Stock Exchange of India Limited that Shashi Kant Shukla, Shailendra Kumar Pandey, Vishal Shishodia, and Rakesh Kumar Srivastava ceased to be senior managerial personnel of the company from the close of business hours on August 31, 2026, following a transfer of their employment to resulting companies as part of a scheme of arrangement.
1 week agoCapital Market - Live
Corporate
Corporate
India Glycols shareholders to receive shares from Ennature and IGL Spirits via arrangementIndia Glycols Limited informed the BSE Limited and National Stock Exchange of India Limited that its Board of Directors has fixed September 1, 2026, as the Effective Date and September 2, 2026, as the Record Date for the allotment of shares pursuant to a Scheme of Arrangement involving India Glycols Limited, Ennature Bio Pharma Limited, and IGL Spirits Limited. Under the scheme, Ennature Bio Pharma Limited will issue one equity share for every three equity shares held in India Glycols Limited, while IGL Spirits Limited will issue one equity share for every one equity share held in India Glycols Limited.
3 weeks agoCapital Market - Live
Earnings
Earnings
India Glycols Ltd consolidated sales up 15.78% on year in Q2FY2026, net profit expanded by 11.45%India Glycols Ltd share price softened by 1.13% to Rs 1072.35. The Company's net profit rose by 11.45% to Rs 96.83 crore, while revenue from operations edged up 15.78% to Rs 1130.39 crore in Q2FY26 over Q1FY26. The market capitalization of Breweries & Distilleries industry group stocks on BSE stood at Rs 2.3 lakh crore, rising 9.35%. It has eased by 0.74% over last one week and jumped by 16.03% in last one month while the market capitalization of India Glycols Ltd has slipped by 9.13% and 3.41% in the same period respectively. Profit before tax (PBT) of India Glycols Ltd stood at Rs 122.88 crore in Q2 FY26, rallying 35.73% year-on-year, and gaining 9.27% quarter-on-quarter. EBITDA came in at Rs 169 crore, improving 14.13% YoY and easing 1.99% sequentially. Total expenses increased by 17.89% to Rs 1003.31 crore in Q2FY26 over Q2FY25. During the quarter, cost of materials consumed stood at Rs 678.45 crore, jumping 39.98% YoY, while employee benefits expense was at Rs 37.53 crore, improving by 9.70% YoY. For the TTM ended FY26, revenue from operations advanced 11.76% to Rs 4211.41 crore, while net profit soared by 26.78% to Rs 292.76 crore, compared to previous TTM. EBITDA jumped by 53557% to Rs 644.32 crore, and PBT jumped 29.04% to Rs 377.21 crore compared to previous TTM. The company's consolidated net cash flow from operating activities stood at Rs 769.17 crore in FY26, as against Rs 362.11 crore in FY25. India Glycols Ltd surged by 18% in last one year, significantly outperforming the benchmark BSE Sensex which has softened by 3.04% during the same period.
1 month agoCapital Market - Live
Corporate
Corporate
India Glycols redesignates Pragya Bhartia Barwale as Non-Executive Non-Independent DirectorIndia Glycols Limited announced that its Board of Directors redesignated Ms. Pragya Bhartia Barwale from Whole Time Director and Key Managerial Person to Non-Executive Non-Independent Director, effective at the closure of business hours on August 12, 2026.
1 month agoCapital Market - Live
Corporate
Corporate
India Glycols to review first-quarter results at a board meeting on August 12, 2026India Glycols Limited will hold a board meeting on Wednesday, 12th August, 2026, to consider and approve the Unaudited Financial Results (Standalone & Consolidated) for the first quarter ended 30th June, 2026, and the information will be hosted on the company’s website at www.indiaglycols.com; the trading window for the company's securities, which was closed on Wednesday, 1st July, 2026, will remain closed until Friday, 14th August, 2026.
1 month agoCapital Market - Live
Corporate
Corporate
India Glycols to review first-quarter results at a board meeting on August 12, 2026India Glycols Limited will hold a board meeting on Wednesday, 12th August, 2026, to consider and approve the Unaudited Financial Results (Standalone & Consolidated) for the first quarter ended 30th June, 2026, and the information will be hosted on the company’s website at www.indiaglycols.com; the trading window for the company's securities, which was closed on Wednesday, 1st July, 2026, will remain closed until Friday, 14th August, 2026.
1 month agoCapital Market - Live
Corporate
Corporate
India Glycols to convene AGMIndia Glycols announced that the Annual General Meeting(AGM) of the company will be held on 19 August 2026.
1 month agoCapital Market - Live
Earnings
Earnings
India Glycols consolidated net profit rises 35.71% in the March 2026 quarterNet profit of India Glycols rose 35.71% to Rs 86.88 crore in the quarter ended March 2026 as against Rs 64.02 crore during the previous quarter ended March 2025. Sales rose 13.11% to Rs 976.35 crore in the quarter ended March 2026 as against Rs 863.22 crore during the previous quarter ended March 2025. For the full year,net profit rose 26.78% to Rs 292.76 crore in the year ended March 2026 as against Rs 230.92 crore during the previous year ended March 2025. Sales rose 11.76% to Rs 4211.41 crore in the year ended March 2026 as against Rs 3768.26 crore during the previous year ended March 2025. ParticularsQuarter EndedYear EndedMar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var. Sales976.35863.22 13 4211.413768.26 12 OPM %17.0516.91 -15.4213.56 - PBDT153.69114.38 34 533.42407.52 31 PBT112.4681.79 37 378.04292.32 29 NP86.8864.02 36 292.76230.92 27 Powered by Capital Market - Live
4 months agoCapital Market - Live
Corporate
Corporate
India Glycols to discuss resultsIndia Glycols will hold a meeting of the Board of Directors of the Company on 14 May 2026.
4 months agoCapital Market - Live
Corporate
Corporate
Board of India Glycols recommends interim dividendIndia Glycols announced that the Board of Directors of the Company at its meeting held on 17 March 2026, inter alia, have recommended the interim dividend of Rs 7.5 per equity Share (i.e. 150%) , subject to the approval of the shareholders.Powered by Capital Market - Live
5 months agoCapital Market - Live
Over the last 5 years, revenue has grown at a yearly rate of 12.6%, vs industry avg of 14.06%
Over the last 5 years, market share increased from 3.01% to 3.15%
Over the last 5 years, net income has grown at a yearly rate of 17.34%, vs industry avg of 9.87%